Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 1,326 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Validation Clear all

Conditions: Postural Tachycardia Syndrome
Interventions: NET mRNA level, Plasma catechols, Urine Catechols; Diagnostic Test
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 13 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Dental Caries
Interventions: Fluoride; Drug
Lead sponsor: Indiana Nanotech, LLC; Other
Eligibility: 13 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Ovarian Cancer, Stage IV Ovarian Cancer
Interventions: Laboratory Biomarker Analysis; Other
Lead sponsor: Gynecologic Oncology Group; Network
Eligibility: Female only
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Burns, Wound Heal, Wounds and Injuries
Interventions: DeepView SnapShot Portable (DV-SSP); Device
Lead sponsor: SpectralMD; Industry
Eligibility: Not listed
Enrollment: 274 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 21
States / cities: Phoenix, Arizona • Sacramento, California • San Diego, California + 17 more

Conditions: Hemorrhagic Stroke, Intracerebral, Cerebral Cavernous Malformation
Interventions: CCM Hemorrhagic Panel; Diagnostic Test
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 10 Years to 78 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Constipation
Interventions: Not listed
Lead sponsor: The SmartPill Corporation; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 12
States / cities: Tucson, Arizona • Los Angeles, California • Iowa City, Iowa + 9 more

Conditions: Glioma, Malignant Brain Neoplasm, Meningioma, Metastatic Malignant Neoplasm in the Brain
Interventions: Advanced Magnetic Resonance Imaging, Brain Surgery, Electronic Health Record Review, Immuno-Positron Emission Tomography Scan, Magnetic Resonance Imaging, Stereotactic Biopsy, Zirconium Zr 89 Crefmirlimab Berdoxam; Procedure · Other · Diagnostic Test
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Congestive Heart Failure, Ischemic Cardiomyopathy, Mitral Valve Prolapse, Mitral Regurgitation, Aortic Valve Disease, Tricuspid Regurgitation
Interventions: Not listed
Lead sponsor: Woolsthorpe Technologies, LLC; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 3
States / cities: Nashville, Tennessee • Houston, Texas

Conditions: Respiratory Distress, Acute Lung Injury
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia, Cerebral Vasospasm, Autonomic Nervous System Diseases
Interventions: Right-Sided Cervical Sympathetic Block at C6, Transcutaneous Auricular Vagal Nerve Stimulation (taVNS); Procedure · Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Anemia
Interventions: Biotin-Labeled Red Blood Cells (RBCs); Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cardiac Arrhythmias, Electroanatomic Mapping, Cardiac Ablation
Interventions: Rhythmia Mapping System; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rosacea
Interventions: buccal swab; Genetic
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 306 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Redwood City, California

Conditions: COVID-19
Interventions: Not listed
Lead sponsor: Cantor BioConnect, Inc.; Network
Eligibility: 5 Years and older
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 6
States / cities: South Gate, California • Hollywood, Florida • Pembroke Pines, Florida + 2 more

Conditions: Schizophrenia, Schizo Affective Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Burns Involving 20% or More of Body Surface
Interventions: Blood Draw; Procedure
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 3
States / cities: Dallas, Texas • Fort Sam Houston, Texas • Houston, Texas

Conditions: Ovarian Cancer
Interventions: Blood-Based Ovarian Cancer Screening Test; Diagnostic Test
Lead sponsor: Mercy BioAnalytics, Inc.; Industry
Eligibility: 50 Years and older · Female only
Enrollment: 1,750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Waltham, Massachusetts • Austin, Texas

Conditions: Parkinson Disease
Interventions: Procedure/Surgery: Biofluid samplings; Procedure
Lead sponsor: Michael J. Fox Foundation for Parkinson's Research; Other
Eligibility: 30 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 5
States / cities: Chicago, Illinois • Boston, Massachusetts • Portland, Oregon + 2 more

Conditions: Rare CNS Tumor, FOXR2-activated, BCOR ITD Sarcoma, CNS Sarcoma, PLAG-altered Tumors, Mesenchymal Tumor
Interventions: Personalized Treatment Recommendation; Other
Lead sponsor: Adriana Fonseca; Other
Eligibility: Up to 45 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Neonatal Respiratory Failure, Congenital Heart Defect
Interventions: Measurement of oxygen consumption and caloric expenditure; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Up to 12 Months
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction
Interventions: New York Heart Association Classification Guide; Other
Lead sponsor: Board of Trustees of Illinois State University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Aurora, Colorado • Normal, Illinois • Lancaster, Pennsylvania

Conditions: Vision, Low, Blindness
Interventions: Interaction with Mock COVID-19 Rapid Antigen Test and Reference Surfaces, Biomechanical Measurements, Psychophysical Tasks; Diagnostic Test · Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 12 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Unplanned Hospital Readmissions, Patients at High Risk of Unplanned Readmission
Interventions: Epic 30-day unplanned readmission risk score; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Generalized Anxiety Disorder
Interventions: Alprazolam (Xanax), Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: San Diego, California

Search by objective public record fields.

POTS NET mRNA Functional Correlation With NET Activity

Development and Validation of a Multi-Mineral Fluoride Mouthrinse

Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Burn Validation Study

CCM Blood Biomarker Validation Study

Colonic Transit Time Validation Study

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Cardiac Output Pulmonary Arterial Catheter Compared to FloWave™ 1000

Lung Injury Prediction Study

Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage

Transfusion of Biotinylated Red Blood Cells

Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias

Genetic Basis of Rosacea

Bioaerosol Sampling Device (BSD) Clinical Study

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

Identification and Validation of Biomarkers for Infections in Burns

Safety in Ovarian Cancer for Average-Risk Women - Analysis

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)

Ultra-Rapid Profiling and Drug Screening for Treatment Selection in Patients With Relapsed or Recurrent Rare Brain Tumors

Validation of a Novel Oxygen Consumption Measurement Technique in Neonates

Consistently Assess Signs and Symptom of Heart Failure

Validation of Texture Changing Coatings for Use in At-Home Rapid Tests

Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model

Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder